Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma The CARCINOVIC Cohort - Université de Rennes Access content directly
Journal Articles Liver International Year : 2019

Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma The CARCINOVIC Cohort

Pierre Nahon
  • Function : Author
  • PersonId : 878824

Abstract

Background & Aims: HIV/HCV co-infected patients with hepatocellular carcinoma (HCC) have poorer survival than HCV mono-infected patients. We aimed to evaluate the prognostic factors for survival.Methods: From 2006 to 2013, 55 incident HCCs among HIV+/HCV+ patients, from three ANRS cohorts, were compared with 181 HCCs in HIV−/HCV+ patients from the ANRS Cirvir cohort.Results: HIV+/HCV+ patients were younger (50 years [IQR: 47‐53] vs 62 [54‐70], P < 0.001), male (89% vs 63%, P < 0.001) than HIV−/HCV+ patients. At HCC diagnosis, both groups had a majority of non‐responders to anti‐HCV‐therapy, and HIV+/HCV+ patients had more frequently known a previous cirrhosis decompensation (31% vs 14%, P = 0.005). At diagnostic imaging, there were more infiltrative forms of HCC in HIV+/HCV+ group (24% vs 14%, P < 0.001), associated with tumour portal thrombosis in 29%. During a median follow‐up period of 11.96 [5.51‐27] months since HCC diagnosis, a majority of palliative treatments were decided in HIV+/HCV+ patients (51% vs 19%, P < 0.001). The 1 and 2‐year crude survival rates were 61% versus 78% and 47% versus 63%, P = 0.003 respectively. In a Cox model multivariate analysis adjusted for the cohort, age and sex, the most important prognostic factor for survival was the infiltrative form of the tumour (aRR: 8.10 [4.17‐15.75], P < 0.001).Conclusions: The radiological aggressiveness of the tumour is the best prognostic factor associated with poorer survival of HCC in HIV+/HCV+ patients. High α‐foetoprotein level and decompensated cirrhosis are other ones. This justifies a particular attention to the detection and the management of small nodules in this high‐risk population.
Fichier principal
Vignette du fichier
Gelu‐Simeon et al_Prognostic factors of survival in HIV-HCV co-infected patients with.pdf (619.96 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01874554 , version 1 (20-09-2018)

Identifiers

Cite

Moana Gelu-Simeon, Maïté Lewin, Maria Ostos, Tatiana Bayan, Maria Beso Delgado, et al.. Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma The CARCINOVIC Cohort. Liver International, 2019, 39 (1), pp.136-146. ⟨10.1111/liv.13921⟩. ⟨hal-01874554⟩
311 View
421 Download

Altmetric

Share

Gmail Facebook X LinkedIn More